Molecular evidence for a single clonal origin in biphenotypic concomitant chronic lymphocytic leukemia and multiple

D L Saltman1, J A Ross, R E Banks

  • 1Medical Research Council Human Genetics Unit, Western General Hospital, Edinburgh, Scotland.

Blood
|November 1, 1989
PubMed

Insights

This study investigated the origins of chronic lymphocytic leukemia and multiple myeloma. Both cancers likely arose from a single B-cell progenitor, indicated by identical immunoglobulin gene rearrangements.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Investigating the clonal origin of concomitant B-cell chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) is crucial for understanding their pathogenesis.
  • Concomitant CLL (IgM kappa) and MM (IgA lambda) present a diagnostic and therapeutic challenge due to distinct clinical and biological features.

Observation:

  • Analysis of immunoglobulin (Ig) gene rearrangements in patient blood and bone marrow was performed.
  • Identical heavy chain gene (JH) rearrangements were observed in both CLL and MM samples, despite differing light chain isotypes (kappa and lambda).
  • Peripheral blood lymphocytes showed rearrangements in both kappa and lambda light chain genes, suggesting their involvement in myeloma.

Findings:

  • Pre-treatment analysis revealed identical JH rearrangements in blood and bone marrow for both CLL and MM.
  • Post-chemotherapy analysis showed stable JH and CK rearrangements but a return to germline configuration for lambda genes.
  • These findings strongly suggest a shared B-cell progenitor for both lymphoid malignancies in this patient.

Implications:

  • The study supports the hypothesis of a common cellular origin for distinct B-cell malignancies.
  • Understanding the clonal evolution of concomitant CLL and MM can inform treatment strategies.
  • This research contributes to the broader understanding of lymphomagenesis and B-cell differentiation pathways.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...